397 related articles for article (PubMed ID: 22151936)
41. Usefulness of retinoic acid in the treatment of melasma.
Pathak MA; Fitzpatrick TB; Kraus EW
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
[TBL] [Abstract][Full Text] [Related]
42. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
[TBL] [Abstract][Full Text] [Related]
43. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.
Haddad AL; Matos LF; Brunstein F; Ferreira LM; Silva A; Costa D
Int J Dermatol; 2003 Feb; 42(2):153-6. PubMed ID: 12709008
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial.
Iraji F; Faghihi G; Siadat AH; Enshaieh S; Shahmoradi Z; Joia A; Soleimani F
J Drugs Dermatol; 2010 Aug; 9(8):964-8. PubMed ID: 20684146
[TBL] [Abstract][Full Text] [Related]
45. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
[TBL] [Abstract][Full Text] [Related]
46. [Use of a cream based on 20% azelaic acid in the treatment of melasma].
Rigoni C; Toffolo P; Serri R; Caputo R
G Ital Dermatol Venereol; 1989; 124(1-2):I-VI. PubMed ID: 2767714
[TBL] [Abstract][Full Text] [Related]
47. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
[TBL] [Abstract][Full Text] [Related]
48. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Rendon M; Dryer L
J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of glycolic acid peels in the treatment of melasma.
Hurley ME; Guevara IL; Gonzales RM; Pandya AG
Arch Dermatol; 2002 Dec; 138(12):1578-82. PubMed ID: 12472345
[TBL] [Abstract][Full Text] [Related]
50. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
52. Glycolic Acid peels/azelaic Acid 20% cream combination and low potency triple combination lead to similar reduction in melasma severity in ethnic skin: results of a randomized controlled study.
Mahajan R; Kanwar AJ; Parsad D; Kumaran MS; Sharma R
Indian J Dermatol; 2015; 60(2):147-52. PubMed ID: 25814702
[TBL] [Abstract][Full Text] [Related]
53. The Effect of Topical Use of Petroselinum Crispum (Parsley) Versus That of Hydroquinone Cream on Reduction of Epidermal Melasma: A Randomized Clinical Trial.
Khosravan S; Alami A; Mohammadzadeh-Moghadam H; Ramezani V
Holist Nurs Pract; 2017; 31(1):16-20. PubMed ID: 27902522
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
[TBL] [Abstract][Full Text] [Related]
55. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
Torok H; Taylor S; Baumann L; Jones T; Wieder J; Lowe N; Jarret M; Rich P; Pariser D; Tschen E; Martin D; Menter A; Weiss J
J Drugs Dermatol; 2005; 4(5):592-7. PubMed ID: 16167418
[TBL] [Abstract][Full Text] [Related]
56. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
Hantash BM; Jimenez F
J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
El-Husseiny R; Rakha N; Sallam M
Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
[TBL] [Abstract][Full Text] [Related]
58. Interventions for melasma.
Rajaratnam R; Halpern J; Salim A; Emmett C
Cochrane Database Syst Rev; 2010 Jul; (7):CD003583. PubMed ID: 20614435
[TBL] [Abstract][Full Text] [Related]
59. The Tam formula: A pilot study for a new treatment for melasma.
Srivastava R; John AM; Tam A; Firoz BF
J Cosmet Dermatol; 2021 Jul; 20(7):2168-2171. PubMed ID: 33206439
[TBL] [Abstract][Full Text] [Related]
60. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea.
Bjerke R; Fyrand O; Graupe K
Acta Derm Venereol; 1999 Nov; 79(6):456-9. PubMed ID: 10598760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
